Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,041 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Noninvasive Evaluation of GIP Effects on β-Cell Mass Under High-Fat Diet.
Kiyobayashi S, Murakami T, Harada N, Fujimoto H, Murata Y, Fujita N, Hamamatsu K, Ikeguchi-Ogura E, Hatoko T, Lu X, Yamane S, Inagaki N. Kiyobayashi S, et al. Among authors: fujimoto h. Front Endocrinol (Lausanne). 2022 Jul 12;13:921125. doi: 10.3389/fendo.2022.921125. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35909510 Free PMC article.
Noninvasive longitudinal quantification of β-cell mass with [111In]-labeled exendin-4.
Fujita N, Fujimoto H, Hamamatsu K, Murakami T, Kimura H, Toyoda K, Saji H, Inagaki N. Fujita N, et al. Among authors: fujimoto h. FASEB J. 2019 Nov;33(11):11836-11844. doi: 10.1096/fj.201900555RR. Epub 2019 Aug 1. FASEB J. 2019. PMID: 31370679 Free PMC article.
This technique successfully demonstrated longitudinal changes in BCM in NOD mice before and after onset of hyperglycemia.-Fujita, N., Fujimoto, H., Hamamatsu, K., Murakami, T., Kimura, H., Toyoda, K., Saji, H., Inagaki, N. ...
This technique successfully demonstrated longitudinal changes in BCM in NOD mice before and after onset of hyperglycemia.-Fujita, N., Fuj …
First-in-Human Evaluation of Positron Emission Tomography/Computed Tomography With [18F]FB(ePEG12)12-Exendin-4: A Phase 1 Clinical Study Targeting GLP-1 Receptor Expression Cells in Pancreas.
Fujimoto H, Fujita N, Hamamatsu K, Murakami T, Nakamoto Y, Saga T, Ishimori T, Shimizu Y, Watanabe H, Sano K, Harada N, Nakamura H, Toyoda K, Kimura H, Nakagawa S, Hirai M, Murakami A, Ono M, Togashi K, Saji H, Inagaki N. Fujimoto H, et al. Front Endocrinol (Lausanne). 2021 Aug 19;12:717101. doi: 10.3389/fendo.2021.717101. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34489868 Free PMC article. Clinical Trial.
Preservation effect of imeglimin on pancreatic β-cell mass: Noninvasive evaluation using 111In-exendin-4 SPECT/CT imaging and the perspective of mitochondrial involvements.
Fauzi M, Murakami T, Fujimoto H, Botagarova A, Sakaki K, Kiyobayashi S, Ogura M, Inagaki N. Fauzi M, et al. Among authors: fujimoto h. Front Endocrinol (Lausanne). 2022 Sep 29;13:1010825. doi: 10.3389/fendo.2022.1010825. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36246910 Free PMC article.
Synthesis and biological evaluation of an 111In-labeled exendin-4 derivative as a single-photon emission computed tomography probe for imaging pancreatic β-cells.
Kimura H, Fujita N, Kanbe K, Matsuda H, Watanabe H, Arimitsu K, Fujimoto H, Hamamatsu K, Yagi Y, Ono M, Inagaki N, Saji H. Kimura H, et al. Among authors: fujimoto h. Bioorg Med Chem. 2017 Oct 15;25(20):5772-5778. doi: 10.1016/j.bmc.2017.09.005. Epub 2017 Sep 7. Bioorg Med Chem. 2017. PMID: 28927802
Evaluation of 18F-labeled exendin(9-39) derivatives targeting glucagon-like peptide-1 receptor for pancreatic β-cell imaging.
Kimura H, Ogawa Y, Fujimoto H, Mukai E, Kawashima H, Arimitsu K, Toyoda K, Fujita N, Yagi Y, Hamamatsu K, Murakami T, Murakami A, Ono M, Nakamoto Y, Togashi K, Inagaki N, Saji H. Kimura H, et al. Among authors: fujimoto h. Bioorg Med Chem. 2018 Jan 15;26(2):463-469. doi: 10.1016/j.bmc.2017.12.007. Epub 2017 Dec 5. Bioorg Med Chem. 2018. PMID: 29273416
1,041 results